Review ArticlesUnique Imaging Findings of Neurologic Phantosmia Following Pfizer-BioNtech COVID-19 Vaccination: A Case ReportKeir, Graham MD∗; Maria, Naomi I. PhD†; Kirsch, Claudia F.E. MD‡Author Information ∗Department of Radiology, North Shore University Hospital-Long Island Jewish Radiology Residency, Zucker Hofstra School of Medicine, Northwell Health, Manhasset, NY †Feinstein Institutes for Medical Research, Institute of Molecular Medicine, Northwell Health, Manhasset, NY ‡Department of Radiology, Northwell Health, Zucker Hofstra School of Medicine at Northwell, North Shore University Hospital, Manhasset, NY. Address correspondence to Claudia F.E. Kirsch, MD, Division Chief Neuroradiology, Professor of Neuroradiology and Otolaryngology, Department of Radiology Northwell Health, Zucker Hofstra School of Medicine at Northwell, North Shore University Hospital, 300 Community Dr, Manhasset, NY 11030 (e-mail: [email protected], [email protected]). No funding was received for this manuscript or work within. Topics in Magnetic Resonance Imaging: June 2021 - Volume 30 - Issue 3 - p 133-137 doi: 10.1097/RMR.0000000000000287 Buy Metrics Abstract Olfactory dysfunction related to SARS-CoV-2 infection and COVID-19 disease is now well established in the literature. In December 2020, the FDA approved the Pfizer-BioNTech and Moderna vaccines for use in preventing COVID-19 in the United States. To the best of our knowledge, this is the first report of a phantosmia post-Pfizer COVID-19 vaccination, with positive magnetic resonance imaging radiographic findings in a patient with documented absence of infection by SARS-CoV-2 virus or concomitant sinonasal disease. Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.